We asked ourselves which is the technology that is widespread both in wealthy and developing countries and which is the most cost/effective tool that we have for the diagnosis of basic cardiovascular diseases?
So, we conceived our solution, D-Heart. By integrating the economic sustainability and the scientific accuracy of electrocardiographs with a widespread tool such as mobile connection, we are trying to reinvent the concept of Cardiovascular Screening and widening the range of individuals capable of self-screening.
We thereby propose a device, which is simple, cheap and portable that would allow a broader range of previously medically ‘abandoned’ subjects to obtain a proper cardiovascular screening.
Everyone, if equipped with a smartphone or tablet would be able to correctly place the electrodes on themselves or a third part, acquire the ECG tracing via Bluetooth and share it remotely at nearest cardiological hospital for the response.
What differentiates D-Heart in respect to the competitors is the reliability also in non-expert hands, low cost but particularly portability and efficiency during emergency.
So, we conceived our solution, D-Heart. By integrating the economic sustainability and the scientific accuracy of electrocardiographs with a widespread tool such as mobile connection, we are trying to reinvent the concept of Cardiovascular Screening and widening the range of individuals capable of self-screening.
We thereby propose a device, which is simple, cheap and portable that would allow a broader range of previously medically ‘abandoned’ subjects to obtain a proper cardiovascular screening.
Everyone, if equipped with a smartphone or tablet would be able to correctly place the electrodes on themselves or a third part, acquire the ECG tracing via Bluetooth and share it remotely at nearest cardiological hospital for the response.
What differentiates D-Heart in respect to the competitors is the reliability also in non-expert hands, low cost but particularly portability and efficiency during emergency.
Location: Italy, Liguria, Genoa
Employees: 1-10
Phone: +39 010 301 7000
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | H+ Digital... | healthplus... |
Mentions in press and media 3
| Date | Title | Description |
| 23.01.2017 | German smartphone ECG maker CardioSecur raises $5.36M | Personal MedSystems, a German medical device company better known by its brand name CardioSecur, has raised $5.36 million (5 million euros). KPN Ventures led the round, with additional contributions from new investors Sino-German High-Tech ... |
| 11.06.2012 | Company developing #mhealth ECG device for iPhone, iPad raises $10.5M | New investor Khosla Ventures joined existing investor Burrill & Company to lead the funding round. The investment from Khosla Ventures earns the Menlo Park, California venture capital firm a seat on the board, which will be occupied by ... |
| - | Company developing #mhealth ECG device for iPhone, iPad raises $10.5M | Some people may firmly believe that developing mobile medical apps is too risky for patients. But companies like AliveCor in San Francisco is showing that investors don’t share that sentiment when it comes to the future of #mhealth. The com... |